WASHINGTON, D.C.: Market research titled Mild Cognitive Impairment – Pipeline Review, H2 2015 is a report providing data and information that helps strengthen R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Complete report on Mild Cognitive Impairment pipeline spread across 93 pages, analyzing 11 companies, 21 drug profiles and supported with 28 tables and 15 figures is now available.